-
Oct 25, 2022
-
Apr 17, 2020
-
Nov 15, 2019
AmnioChor Secures 9th Global Patent With Partner Rutgers University
Your Baby’s Stem Cells Are Much More Powerful & Plentiful Than You Thought
AmnioChor Secures 9th Global Patent With Partner Rutgers University
AmnioChor is a biotech company based in perinatal stem cell technology. The Company has identified a source and method of acquiring and preserving human stem cells. AmnioChor’s stem cells will allow a tremendous expansion of the private stem cell storage industry and stem cell based therapies to augment the cord blood banking industry.